Logo Image
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Dr. Alfonso Gomez de Liaño Lista

Advertisement

Articles by Dr. Alfonso Gomez de Liaño Lista

The UroOnc Minute: KEYNOTE-B15 and Perioperative Therapy in MIBC, With Dr Alfonso Gómez de Liaño Lista

ByAdam B. Weiner, MD,Dr. Alfonso Gomez de Liaño Lista
April 17th 2026

In this episode of The UroOnc Minute, host Adam B. Weiner, MD, is joined by Dr Alfonso Gómez de Liaño Lista for a timely discussion on a practice-changing development in muscle-invasive bladder cancer: the phase 3 KEYNOTE-B15 trial.

Advertisement

Latest Updated Articles

  • The UroOnc Minute: KEYNOTE-B15 and Perioperative Therapy in MIBC, With Dr Alfonso Gómez de Liaño Lista
    The UroOnc Minute: KEYNOTE-B15 and Perioperative Therapy in MIBC, With Dr Alfonso Gómez de Liaño Lista

    April 17th 2026



Advertisement
Advertisement

Trending on Urology Times

1

Treatment interruptions in prostate cancer: Balancing PSA kinetics and quality of life

2

FDA grants breakthrough therapy designation to 64Cu-SAR-bisPSMA for recurrent prostate cancer imaging

3

American Cancer Society updates prostate cancer screening guidelines, recommends regular PSA testing

4

FDA approves durvalumab plus enfortumab vedotin for cisplatin-ineligible MIBC

5

Detalimogene shows continued activity in BCG-unresponsive NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us